New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

Go back to New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
(NASDAQ: IPSC) Delayed: 2.30 +0.01 (0.44%)
Previous Close $2.29    52 Week High
Open $2.29    52 Week Low
Day High $2.41    P/E N/A 
Day Low $2.27    EPS
Volume 965,244